WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Earnings & Revenue

ETNB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$142.2M
Current Profit Margin
0%

ETNB Return on Equity

Current Company
-31%
Current Industry
-63.5%
Current Market
188%
ETNB's Return on Equity (-31%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ETNB announces earnings.

ETNB Return on Assets

Current Company
-27.8%
Current Industry
2.9%
ETNB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ETNB Return on Capital Employed

Current Company
-23.56%
Current Industry
19.5%
ETNB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ETNB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ETNB$0.00-$133.26M-$142.19MN/AN/A
SPRY$30.00k-$54.29M-$54.37M-92.62%N/A
IMTX$58.69M-$97.57M-$105.43M+69.15%N/A
RLAY$25.55M-$336.70M-$341.97M-88.41%N/A
SAVA$0.00-$95.69M-$97.22MN/AN/A

ETNB earnings dates

Next earnings date
May 2, 2024

89bio Earnings & Revenue FAQ

What were ETNB's earnings last quarter?

On Invalid Date, 89bio (NASDAQ: ETNB) reported Q4 2023 earnings per share (EPS) of -$0.50, up 66.67% year over year. Total 89bio earnings for the quarter were -$40.24 million. In the same quarter last year, 89bio's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy 89bio stock.

What was ETNB's earnings growth in the past year?

As of Q2 2024, 89bio's earnings has grown year over year. 89bio's earnings in the past year totalled -$142.19 million.

What is ETNB's earnings date?

89bio's earnings date is Invalid Date. Add ETNB to your watchlist to be reminded of ETNB's next earnings announcement.

What was ETNB's revenue last quarter?

On Invalid Date, 89bio (NASDAQ: ETNB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, 89bio's revenue was $0.00.

What was ETNB's revenue growth in the past year?

As of Q2 2024, 89bio's revenue has grown null year over year. 89bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.